「head」の検索結果
23件：16～20件目を表示
もしかして
-
l trials in Japan for the novel Dry Eye Disease treatment, SJP-0132 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter: Senju) is developing a compo...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716_0.pdf -
pproval for a BAC-free formulation of Aibeta® combination eye drops Senju Pharmaceutical Co., Ltd. (Head Office: Osaka City, President: Shuhei Yoshida) announced today that it has obtained approval fo...
https://www.senju.co.jp/system/files/content_news/2025-09/ENG_20250904_0.pdf -
pproval for a BAC-free formulation of Aibeta® combination eye drops Senju Pharmaceutical Co., Ltd. (Head Office: Osaka City, President: Shuhei Yoshida) announced today that it has obtained approval fo...
https://www.senju.co.jp/system/files/content_news/2025-09/ENG_20250904.pdf -
Approval in Japan for the novel Dry Eye Disease treatment, SJP-0132 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter: Senju) is developing a TRPV1...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117_0.pdf -
Approval in Japan for the novel Dry Eye Disease treatment, SJP-0132 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter: Senju) is developing a TRPV1...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117.pdf